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Musical Hallucination Caused by Ceftazidime in a Woman with a 
Hearing Impairment
Chan Il Song1, Young-Eun Jung2
1Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, 2Department of Psychiatry, Jeju National University School 
of Medicine, Jeju, Korea
Musical hallucinations remain a poorly understood clinical phenomenon, possibly because these types of hallucination 
have multiple causes and are rarely the focus of published reports. Here, the case of a 51-year-old female patient 
with a hearing impairment who developed musical hallucinations during treatment with ceftazidime, a third-generation 
cephalosporin, is presented. She responded to the discontinuation of ceftazidime and the initiation of low-dose olanza-
pine treatment. Musical hallucinations associated with ceftazidime are very rare, and the mechanisms underlying its 
occurrence remain unknown. Further studies will be necessary to determine the pathophysiology of adverse psychiatric 
reactions associated with ceftazidime.
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INTRODUCTION
Musical hallucinations, which are also known as musi-
cal hallucinosis or musical-ear syndrome, are charac-
terized by songs, tunes, harmonics, rhythms, and/or 
timbers.1) The exact prevalence of musical hallucinations 
is unknown, although estimates as high as 2.5% have 
been reported in older patients with hearing impair-
ments.2) Various types of dysfunction within an extensive 
network of interconnected brain areas are thought to be 
the potential causes of musical hallucinations, but most 
cases are likely due to multifactorial etiologies. The etiol-
ogy of musical hallucinations can be divided into five 
groups: secondary to auditory deprivation, focal cerebral 
lesions, psychiatric pathology, epilepsy, and secondary to 
pharmaceuticals or metabotoxic causes.3-7)
Here, the case of a patient with no personal or family 
history of psychiatric disorders who complained of musi-
cal hallucinations associated with the administration of 
ceftazidime is presented. Ceftazidime is a third-gen-
eration cephalosporin that belongs to a group of beta-lac-
tam antibiotics used for the treatment of severe infections, 
particularly ciprofloxacin-resistant Pseudomonas aerugi-
nosa infections. Ceftazidime is associated with several ad-
verse reactions within the central nervous system, includ-
ing headaches, dizziness, convulsions, manic episodes, 
and hallucinations.8-12) To our knowledge, this is the first 
report of musical hallucinations associated with ceftazi-
dime in the absence of other neurological or psychiatric 
symptoms. 
CASE
A 51-year-old woman presented for a consultation for 
bilateral otorrhea at our otorhinolaryngology department. 
The patient had tympanic membrane perforations and ac-
tive pus discharge in both ears; a bacterial culture of the 
otorrhea samples showed ciprofloxacin-resistant P. 
aeruginosa. Computed tomography (CT) scans of the tem-
poral bone revealed chronic otitis media in both ears. 
Although the patient had hearing impairments in both 
ears, it was possible to appropriately communicate with 
her because she had speech discrimination scores of 96% 
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for both ears without hearing aids on a speech audiometry 
exam. Her condition was diagnosed as bilateral chronic 
otitis media; thus, surgery and administration of anti-
bacterial agents were recommended as treatment. 
However, the patient did not want to undergo surgery and 
was treated only with intravenous administrations of cef-
tazidime (2 g/day), which is a third-generation cepha-
losporin effective against ciprofloxacin-resistant P. 
aeruginosa. The patient complained of auditory halluci-
nations that began 1 to 2 days after administration of 
ceftazidime. She had suddenly begun hearing songs with 
lyrics that repeated themselves indefinitely before chang-
ing into different pieces of music. In the beginning, the 
music was soft and did not interfere with her daily life, but 
the loudness of the music eventually increased, and the 
musical hallucinations were present from the moment she 
awoke until late at night. 
The patient was thoroughly assessed, but neurological 
examinations and a brain CT scan revealed no significant 
abnormalities. Blood examinations, including a hemo-
gram and liver function, kidney function, serum electro-
lyte, and thyroid function tests, were all within normal 
limits; there was no individual or family history of any 
psychiatric or medical illness in the index patient, and no 
history of substance abuse was present. A psychiatric in-
terview and examination were unable to identify any fac-
tors responsible for the musical hallucinations other than 
ceftazidime. Thus, administration of ceftazidime was dis-
continued after 2 weeks. However, the musical hallucina-
tions persisted, and the patient began treatment with olan-
zapine tablets (2.5 mg/day). During subsequent follow-up 
visits, the sounds decreased in intensity and did not inter-
fere with her daily life, but were not completely resolved. 
As a result, the olanzapine dose was increased to 5 
mg/day; but, due to increased sedation, it had to be de-
creased to 2.5 mg/day again. The patient was followed for 
approximately 6 months and she maintained improve-
ments.
DISCUSSION
Musical hallucinations are associated with being fe-
male, hearing impairments, brain diseases affecting the 
non-dominant hemisphere, temporal lobe lesions, and 
mental disorders such as depression, schizophrenia, and 
obsessive-compulsive disorder.1) In the present case, the 
musical hallucinations were associated with moderately 
severe-to-severe hearing loss in the absence of other neu-
ropsychiatric conditions. Keshavan and Schooler13) sug-
gested that musical hallucinations derive from memory 
tracts, which is a concept they refer to as “parasitic 
memory.” It has also been suggested that musical halluci-
nations are the result of sensory deprivation and may be 
similar to the effects of sensory deprivation in patients 
with phantom limbs.14)
Previous studies have reported occurrences of ceftazi-
dime-induced encephalopathy with or without hallucina-
tions.9,10,15) The central nervous system effects associated 
with ceftazidime manifest primarily in elderly patients 
(over 60 years of age) and in patients with impaired renal 
function in whom the dose of ceftazidime is not appropri-
ately adjusted. Because ceftazidime is not metabolized 
and is exclusively excreted by the kidney, great care 
should be exercised when administering ceftazidime to 
patients with renal disease.15) A previous report described 
the case of a 62-year-old woman with auditory and visual 
hallucinations in the absence of other psychiatric 
symptoms. The occurrence of hallucinations in this eld-
erly patient was presumed to be due to the prolonged 
half-life of the drug attributable to impaired renal 
clearance.8) Compared to that case, the present patient 
was relatively young and did not have a renal disease. 
Jackson and Berkovic10) suggested that ceftazidime tox-
icity may result in disturbances to deep midline gray mat-
ter which, in turn, cause transient toxic peduncular 
hallucinosis. The patient in that case experienced vivid 
visual and auditory hallucinations that closely resembled 
the nature of peduncular hallucinosis, which is usually as-
sociated with lesions involving the deep midline gray 
matter of the midbrain, hypothalamus, or thalamus. Their 
hypothesis may not be applicable to the present case of 
persistent musical hallucinations that likely arose from 
other underlying mechanisms. However, it was impos-
sible to determine whether the patient had any anatomi-
cal or functional lesions because she refused further eval-
uations with magnetic resonance imaging or an electro-
encephalogram. 
The persistent musical hallucinations in the present pa-
tient may be attributed to delays in identifying the adverse 
drug reaction to ceftazidime. Although the musical hallu-
cinations began just 1 or 2 days after administration of cef-
tazidime, the possible cause of the symptoms was not 
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identified for 2 weeks, and administration of ceftazidime 
was continued during this time. Previous case reports de-
termined that when ceftazidime administration was dis-
continued immediately after symptoms began, hallucina-
tions subsided after several days.8-10)
General recommendations for the treatment of musical 
hallucinations have yet to be established, but a variety of 
therapeutic options have been tried in case reports and 
small case series.1) Treatments are aimed the underlying 
cause, if it is known, but not all patients require treatment, 
as musical hallucinations may be self-limiting and re-
assurance is often sufficient in patients with low levels of 
distress.1) All pharmacological treatments for idiopathic 
musical hallucinations are off-label, and it has been 
shown that some antipsychotics or acetylcholinesterase 
inhibitors have an effect on musical hallucinations.1,16,17)
In conclusion, it is emphasized that although musical 
hallucinations are very rare, clinicians should try to eval-
uate their existence and consider multiple pathologies. 
The majority of cases in which treatment has been effec-
tive depended on the resolution of the underlying cause 
such as suspending the responsible pharmaceuticals. 
However, treating musical hallucinations remains a chal-
lenge as there is currently no curative treatment. Further 
studies will be necessary to determine the pathophysiol-
ogy, natural course, and treatment results of musical 
hallucinations.
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